Cinematic rendering of 18F-DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma

被引：0
|
作者：
Rowe, Steven P. [1 ]
Krueger, Sebastian [2 ]
Gorin, Michael A. [3 ]
Fishman, Elliot K. [4 ]
机构：
[1] Univ N Carolina, Dept Radiol, 101 Manning Dr, Chapel Hill, NC 27514 USA
[2] Siemens Healthineers, Erlangen, Germany
[3] Icahn Sch Med Mt Sinai, Milton & Carroll Petrie Dept Urol, New York, NY USA
[4] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Sch Med, Baltimore, MD USA
来源：
BJUI COMPASS | 2024年 / 5卷 / 06期
关键词：
positron emission tomography; prostate-specific membrane antigen; PSMA;
D O I：
10.1002/bco2.324
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：548 / 550
页数：3
相关论文
共 50 条
  • [31] Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
    Mena, Esther
    Rowe, Steven P.
    Shih, Joanna H.
    Lindenberg, Liza
    Turkbey, Baris
    Fourquet, Aloyse
    Lin, Frank I.
    Adler, Stephen
    Eclarinal, Philip
    McKinney, Yolanda L.
    Citrin, Deborah E.
    Dahut, William
    Wood, Bradford J.
    Chang, Richard
    Levy, Elliot
    Merino, Maria
    Gorin, Michael A.
    Pomper, Martin G.
    Pinto, Peter A.
    Eary, Janet F.
    Choyke, Peter L.
    Pienta, Kenneth J.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (08) : 1184 - 1190
  • [32] 18F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study
    Metser, Ur
    Kulanthaivelu, Roshini
    Chawla, Tanya
    Johnson, Sarah
    Avery, Lisa
    Hussey, Douglas
    Veit-Haibach, Patrick
    Bernardini, Marcus
    Hogen, Liat
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Prospective intraindividual comparison of 18F-PSMA-7Q and 18F-DCFPyL PET/CT in patients with newly diagnosed prostate cancer
    Liu, Yachao
    Zhang, Xiaojun
    Liu, Jiajin
    Zhang, Jinming
    Xu, Baixuan
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (06) : 725 - 730
  • [34] A Rare Presentation of Metastatic Renal Clear Cell Carcinoma to the Tongue Seen on FDG PET
    Basely, Mathieu
    Bonnel, Samantha
    Maszelin, Philippe
    Verdalle, Pierre
    Bussy, Emmanuel
    de Jaureguiberry, Jean-Pierre
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (09) : 566 - 569
  • [35] Comparative study of 18F-DCFPyL PET/CT and 99mTc-MDP SPECT/CT bone imaging for the detection of bone metastases in prostate cancer
    Hu, Xiongjian
    Cao, Yiming
    Ji, Bin
    Zhao, Min
    Wen, Qiang
    Chen, Bin
    FRONTIERS IN MEDICINE, 2023, 10
  • [36] Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma
    Mena, Esther
    Shih, Joanna
    Chung, Joon-Yong
    Jones, Jennifer
    Rabiee, Atoosa
    Monge, Cecilia
    Turkbey, Baris
    Lindenberg, Liza
    Salerno, Kilian E.
    Kassin, Michael
    Wood, Brad
    Hernandez, Jonathan
    Maass-Moreno, Roberto
    Saboury, Babak
    Jakhete, Neha
    Molitoris, Jason K.
    Unger, Keith R.
    Choyke, Peter L.
    Escorcia, Freddy E.
    PLOS ONE, 2022, 17 (11):
  • [37] Breast Carcinoma Metastatic to Renal Oncocytoma Detected on F-18-FDG PET/CT
    Fox, Josef J.
    Rohan, Stephen
    Pandit-Taskar, Neeta
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (05) : 294 - 295
  • [38] 18F-Fluciclovine PET/MRI in a Patient With Squamous Cell Carcinoma of the Uterine Cervix Correlated With 18F-FDG PET/CT
    Nguyen, Nghi C.
    Moon, Chan Hong
    Beriwal, Sushil
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (10) : 802 - 804
  • [39] Assessment of cell proliferation in renal cell carcinoma using dual-phase 18F-fluorodeoxyglucose PET/CT
    Onishi, Rei
    Noguchi, Masanori
    Kaida, Hayato
    Moriya, Fukuko
    Chikui, Katsuaki
    Kurata, Seiji
    Kawahara, Akihiko
    Kage, Masayoshi
    Ishibashi, Masatoshi
    Matsuoka, Kei
    ONCOLOGY LETTERS, 2015, 10 (02) : 822 - 828
  • [40] Increased PSMA-Targeted 18F-DCFPyL Uptake in Peripheral T-Cell Lymphoma
    Milrod, Charles J.
    Brown, Cory
    Mega, Anthony E.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : e338 - e339
12345